Mersana Therapeutics, Inc.: net_income
| Value | {"amount": -88045000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-12-31 |
| Status | current |
| Entity | Mersana Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:14:31.671154+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d7bb8d76-f462-4d40-a737-3b9ea4d37e35
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-21-003370Retrieved: 2026-08-19T14:14:31.671154+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001442836/net-income/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d7bb8d76-f462-4d40-a737-3b9ea4d37e35
History
- no predecessors — first report